The new frontier of medicine is precision.

[Music]

so

[Music]

since the beginning of the covet 19

pandemic

i have been heavily involved in its

management

both from a healthcare system

perspective and a scientific one

one of the member of the women’s brain

project

a non-profit which high co-founded went

already in february in china

and she acted as a source of scientific

information

for the scientists working at the

women’s brain project

once the first data became available

from the chinese population

it appeared that more men were

infected with the virus suffering from

major consequences and dying of it

this was for us a an extremely

important observation because what we do

we study the impact

that sex meaning our dna and gender

meaning our social constructs that we

all carry

have on diseases with a special focus on

brain

and mental diseases later on

more data became available worldwide and

it was confirmed

that in fact more men were

having severe symptoms of the

coronavirus infection

as compared to women and dying even of

it although

women were representing the majority of

the

working force in the healthcare system

at the front line

and scientific hypotheses are based on

the fact that the immune system

of women might be stronger in fighting

the virus

now is this true just for the

coronavirus

or not well actually medicine it is

embedded of these sex and gender

differences

but it seems that we need a pandemic

to get the world recognize it

now but if this is the case

our sex and gender differences

represented in the way we develop

medical solutions for humankind and the

answer is no

a report from last year

describing the number of people included

within

clinical trials for drugs approved by

fda between 2015

and 2017 showed that just 43

of the patients included were women and

this number included also

those indications reflecting disease or

condition

prevalent in women like menopause the

same report pointed to the fact that

only five percent of the patients

included were black

12 percent asian 78 majority

white you might agree with me that the

clinical development in our days

it is based on an average existent

persona

a default human which in fact

historically happened to be

predominantly white

and male now what does this mean for

medicine

well the situation it is not that

good in fact a report

from the general american office in 2001

pointed to the fact that out of 10 drugs

eight were withdrawn from the market

because had major side effects

on the female population mainly we know

that women

are not really included

in phase one and phase two of clinical

trials or underrepresented

and this results in drugs which shows in

this population often

a moderate efficacy and major side

effects

even more striking it is what happened

last year 2019

a drug for hiv to prevent

hiv has been approved but only for men

and the reason is that not even one

single woman was included in the

clinical trial design

this is unacceptable

so how can we solve this well

the future is going to bring us

precision medicine

precision medicine it is the opposite of

shallow medicine what i have described

to you before

to quote erictopol and it is based on

the use of

proteomics genomics metabolomics

information about our socioeconomic

status

about the race of the patient

the ethnicity of the patients the sex

and the gender of the patients

analyzed by artificial intelligence

which means

each of us in this room will have a

medical treatment tailored based on its

own specific needs

but why is this not yet a reality

well the simple answer is that medicine

and mainly artificial intelligence

interpreting medicine

it is biased and those biases

are intrinsic very often in a

non-conscious way in not only those who

are developing the algorithm

but mainly in the data set which is used

for this type

of algorithms it’s a known problem

and that in genomics for example big

data sets

reflect usually 80 kilos

relatively wealthy white men and as a

doctor

i would love to have this type of

patients all the time

but it does not reflect the overall

population

so

this has of course implication for

the way we do solutions and i give you

just an example

recently scientists

were developing and diagnostic tool

based on algorithm that was learning

from data set

and what they’ve realized is that if the

algorithm was trained mainly with

data from female the algorithm

wasn’t accurate enough in diagnosing

chest pathology in men

and the other way around pointing to the

fact that you need both sexes

to make a useful diagnostic

algorithm now this type of sex and

gender differences

are also embedded in brain

and mental diseases and

this is where one of the highest unmet

medical needs

in medicine persists i am a specialist

in alzheimer’s disease

i can tell i can tell you that even in

alzheimer we have sex and gender

differences women represent the majority

of the patients

women progress faster with the cognitive

decline

women have more brain atrophy and they

also represent the majority

of the caregiver task force managing

this condition

for their beloved ones what if we

outsource the solution

to algorithms what if we bring

type of precision medicine and precision

medicine relies on

digital biomarkers which means in this

case

you can download an application on your

mobile and while sitting on the coach of

your living room

you can take a test and this test is

going to assess your risk

of having eventually alzheimer’s disease

it can

tell you if your brain it is a normal

one

working properly if it has already

symptoms of

what is called mild cognitive impairment

the phase before

the full alzheimer’s disease becomes

manifested but now the interesting part

comes

what if we ask the algorithm if the

brain performing the test

it is a female brain or a male brain

and actually the answer is that yes the

algorithm can distinguish it

so based on certain type of classifier

it can tell

without the person taking the test it is

a female or a male one

so we need to use this type of

technology to analyze eventually how

diseases

are affecting men and women in a

different way

in what domains of our brain performance

this

has a meaning and implemented in the way

we do develop clinical trials to bring

the medicine of the future with us

now the solution it is precision

medicine which has in fact the potential

of transforming

basically the treatment of brain and

mental

diseases and to do that

will mean that we will reduce the cost

of the healthcare system we will have

better drugs they will act better they

will be tailored

for the person sitting here each of us

and this is

at the right time at the right moment

for the right medical condition

but for doing that we need to do in my

opinion four things mainly

the first one it is to educate to this

type of

differences educate the scientific

community

policy makers regulators drug developers

even the lay public and novel technology

designers

we need to be aware that there is a risk

of having algorithms which might be bias

and if this is the case we have to

mitigate this risk

and avoid that it get implemented and

perpetuated in the system

we need to activate always a strong

ethical discussion

for both clinical solutions

treatments but also for novel technology

design such as the solution that we are

designing

it is meant to benefit the overall

population

and finally we need to make artificial

intelligence which is

explainable we need to know why

artificial intelligence has taken that

decision

at that moment and finally we need to

make it also

reproducible which means the result has

to be reproduced in different parts of

the world

to be actually really true

so 2020 has been a

very very difficult year for science and

medicine

and we have seen that we still have a

lot of work

to do i think that out of this tragedy

we have the unique opportunity to

transform

health care system and medicine

to make it sustainable to make it

representative of the characteristic of

each of us

when we do design drugs when we do

design novel technology

when we try to find social solutions for

big problems as the pandemic in my

opinion

the precision medicine will become

a reality once the word differences

which divide each of us will be replaced

by the word characteristic

thank you

[音乐]

所以

[音乐]

自 covet 19 大流行开始以来,

我一直

从医疗保健系统的

角度和科学的角度积极参与其管理

,女性大脑项目的成员之一是

一个非营利性的高合作 成立

于 2 月在中国成立,

一旦从中国人口中获得第一批数据,她就充当了在女性大脑项目工作的科学家的科学信息来源,

似乎有更多的男性

感染了这种病毒,并遭受了

严重的后果和 死于

它对我们来说是一个极其

重要的观察,因为我们所做的是

研究

性别意味着我们的 DNA 和性别

意味着我们的社会

结构对疾病的影响,特别关注

大脑

和精神疾病

。 数据在全球范围内可用,并

证实事实上更多的男性

出现了

冠状病毒感染

的严重症状,因为 尽管

女性代表了前线

医疗保健系统中的大部分劳动力,

而且科学假设是基于这样

一个事实,即女性的免疫

系统现在可能在抗击病毒方面更强大,但她甚至死于女性。

仅对于冠状病毒是正确的,

或者实际上药物并不好,它

嵌入了这些性别和性别

差异,

但似乎我们现在需要一场流行病

才能让世界认识到它,

但如果是这种情况,

我们的性别和性别差异就

体现在我们的方式上

为人类开发医疗解决方案,

答案是否定

的 去年的一份报告

描述了 2015 年至 2017 年间 FDA

批准的药物临床试验的人数

显示,其中只有 43

名患者是女性,

这个数字还包括

那些适应症 反映

更年期女性普遍存在的疾病或状况

同一份报告指出,

只有 5% 包括的患者

中有

12% 是亚洲人 78% 是

白人 您可能同意我的

观点 对

医学

来说,情况并不

好,事实上

,美国总署 2001 年的一份报告

指出,在 10 种药物中,有

8 种

因对女性人群产生重大副作用而退出市场,

主要是我们

知道 女性

并没有真正被

纳入临床试验的第一阶段和第二阶段,

或者代表性不足

,这导致在该人群中显示出的药物

通常

具有中等疗效和主要副作用

更引人注目的是去年发生的事情

2019

预防艾滋病毒的药物

艾滋病毒已获批准,但仅适用于男性

,原因是临床试验设计中甚至没有

一名女性

这是不可接受的,

所以我们如何才能很好地解决这个

问题,未来将给我们带来

精准医学

精准医学它与

我之前向您描述的浅医学相反,

引用 erictopol,它基于

蛋白质组学基因组学代谢组学

信息的使用 关于我们的社会经济

地位

关于患者的种族 患者

的种族 由人工智能分析的患者的性别

和性别

意味着我们在这个房间里的每个人都将

根据自己的具体需求接受定制的治疗,

但为什么 这还不是

现实,简单的答案是医学

,主要是人工智能

解释医学,

它是有偏见的,这些偏见

通常以

一种无意识的方式固有,不仅

在开发算法的人中,

而且主要在数据集中

用于这种类型

的算法,这是一个已知问题

,并且在基因组学中,例如大

数据集

反映 通常有 80 公斤

相对富裕的白人男性,作为一名

医生,

我希望一直有这类

患者,

但这并不能反映整体

人口,

所以

这当然对

我们解决问题的方式有影响,我只给

你一个 例如,

最近科学家

们正在开发

基于从数据集学习的算法的诊断工具

,他们意识到,如果该

算法主要使用

来自女性的数据进行训练,那么该

算法在诊断男性

和 反过来指出这样一个

事实,即您需要两性

来制定有用的诊断

算法,现在这种类型的性别和

性别差异

也嵌入在大脑

和精神疾病中,

这是医学中未得到满足的最高

医疗需求

之一。

阿尔茨海默病专家

我可以告诉我可以告诉你,即使在

阿尔茨海默病中,我们也存在性别和性别

差异,女性占

多数 f 患者

女性随着认知能力

下降而

进步更快 女性脑萎缩更多,她们

也代表了

大多数照顾者工作组

为他们心爱的人管理这种情况 如果我们

将解决方案外包

给算法 如果我们带来

精准医学类型和 精准

医学依赖于

数字生物标志物,这意味着在这种

情况下,

您可以在手机上下载应用程序

,坐在客厅的教练上

进行测试,该测试

将评估您

最终患上阿尔茨海默病的风险。

告诉你,如果你的大脑在完全阿尔茨海默病出现之前的阶段

已经

出现

了所谓的轻度认知障碍

症状,那么它是否正常工作,但现在有趣的部分

了,如果我们询问算法,

大脑是否执行 测试

它是女性大脑还是男性大脑

,实际上答案是肯定的,

算法可以 区分它,

因此基于某种类型的分类器,

它可以在

没有人参加测试的情况下判断它

是女性还是男性,

因此我们需要使用这种类型的

技术来最终分析疾病如何

以不同的方式影响男性和女性

我们大脑性能的哪些领域

在我们开发临床试验的方式中具有意义并实施,

以将

未来的医学带给我们

现在解决方案是精准

医学,它实际上有可能

从根本上改变

大脑的治疗和

精神

疾病,这样做

将意味着我们将降低

医疗保健系统的成本 我们将拥有

更好的药物 他们将发挥更好的作用 他们

将为

我们每个人坐在这里的人量身定制

,这是

在正确的时间和正确的时间

为了正确的医疗条件,

但为了做到这一点,在我看来,我们需要做

四件事,主要

是第一件事是教育这种

类型的

差异教育sc 科学

社区

政策制定者 监管者 药物开发者

甚至是普通公众和新技术

设计者

我们需要意识到

存在可能存在偏见的算法的风险

,如果是这种情况,我们必须

减轻这种风险

并避免它被实施 并

在系统中持续存在,

我们需要

为临床解决方案

治疗以及新技术

设计(例如我们正在设计的解决方案)始终激活强烈的伦理讨论,

它旨在造福于整个

人群

,最后我们需要制造

人工智能 是

可以解释的,我们需要知道为什么

人工智能在那个时候做出了这个

决定

,最后我们需要

让它也可以

重现,这意味着结果必须

在世界不同地区

重现才能真正成为现实,

所以 2020 年是一个

非常 科学和医学非常艰难的一年

,我们看到我们还有

很多工作

要做 认为在这场悲剧中,

我们有独特的机会来

改变

医疗保健系统和医学

,使其可持续,使其能够

代表我们每个人的特点,

当我们设计药物时,当我们

设计新技术

时,当我们试图找到社会

在我看来,大流行病的大问题的解决方案

一旦

分裂我们每个人的单词差异将

被“特征”这个词取代,精准医学将成为现实,

谢谢